Related Experiment Video
Updated: Nov 26, 2025
03:53
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
1.6K
Death by SARS-CoV 2: a Romanian COVID-19 multi-centre comorbidity study
Anca Pantea Stoian1,2, Mihaela Pricop-Jeckstadt3,4, Adrian Pana5
1University of Medicine and Pharmacy "Carol Davila", 37 Dionisie Lupu Str., 020021, Bucharest, Romania.
Scientific Reports
|December 11, 2020
Summary
This study on COVID-19 fatalities in Romania found that males and conditions like hypertension and diabetes were frequent. However, the overall disease burden was low, with a high 1-year survival probability.
Area of Science:
- Epidemiology
- Public Health
- Infectious Diseases
Background:
- Limited evidence exists on the relationship between SARS-CoV-2 mortality and underlying medical conditions.
- Understanding risk factors is crucial for managing the COVID-19 pandemic.
Purpose of the Study:
- To investigate the association between demographic factors, comorbidities, and COVID-19 mortality in Romania.
- To analyze the burden of disease and survival probability in COVID-19 fatalities.
Main Methods:
- An observational, retrospective study design was employed.
- Data from Romanian official sources on COVID-19 fatalities were analyzed.
- Factors such as location, age, gender, and comorbidities were examined.
Main Results:
- Males, hypertension, diabetes, obesity, and chronic kidney disease were frequently observed in COVID-19 fatalities.
- The overall burden of disease in the sample was low.
- A high 1-year survival probability was noted in the studied population.
Conclusions:
- Specific comorbidities, particularly age-dependent pairs, may negatively influence disease severity in SARS-CoV-2 infections.
- Demographic and comorbidity profiles of COVID-19 fatalities were characterized.
More Related Videos
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
5.8K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.8K
01:05Single Nucleotide Polymorphisms-SNPs
17.4K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.4K
01:21Acute Respiratory Failure-II
785
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
785
01:29Pneumonia II: Pathophysiology
2.0K
The pathophysiology of pneumonia involves the following steps:
2.0K
01:30Pneumonia III: Complications and Assessment
640
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
640
01:30Acute Respiratory Failure-III
534
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
534